J. Goldman & CO LP Reviva Pharmaceuticals Holdings, Inc. Transaction History
J. Goldman & CO LP
- $3.21 Billion
- Q3 2024
A detailed history of J. Goldman & CO LP transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 75,000 shares of RVPH stock, worth $100,500. This represents 0.01% of its overall portfolio holdings.
Number of Shares
75,000Holding current value
$100,500% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RVPH
# of Institutions
40Shares Held
9.97MCall Options Held
133KPut Options Held
43.9K-
Armistice Capital, LLC New York, NY3.19MShares$4.27 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.83MShares$2.46 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.52MShares$2.03 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$1.37 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA685KShares$917,6380.01% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $27.4M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...